We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$1.99B
AUM Growth
+$172M
Cap. Flow
+$156M
Cap. Flow %
7.83%
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294

Sector Composition

Rank Sector Weight
1 Healthcare 2.95%
2 Consumer Discretionary 2.51%
3 Technology 1.96%
4 Energy 1.43%
5 Communication Services 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIBB
926
CALL
DELISTED
Hibbett, Inc. Common Stock
HIBB
-62,500
Closed -$1.43M
UFS
927
CALL
DELISTED
DOMTAR CORPORATION (New)
UFS
-20,000
Closed -$993K
CELG
928
DELISTED
Celgene Corp
CELG
-18,512
Closed -$1.76M
CELG
929
PUT
DELISTED
Celgene Corp
CELG
-531,600
Closed -$50.2M
CZR
930
PUT
DELISTED
Caesars Entertainment Corporation
CZR
-200,000
Closed -$1.74M
RESI
931
DELISTED
Front Yard Residential Corporation Common Stock
RESI
-57,200
Closed -$530K
RESI
932
PUT
DELISTED
Front Yard Residential Corporation Common Stock
RESI
-125,000
Closed -$1.16M
BHVN
933
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-123,400
Closed -$6.96M
FDC
934
DELISTED
First Data Corporation
FDC
-130,000
Closed -$3.42M
FDC
935
PUT
DELISTED
First Data Corporation
FDC
-75,000
Closed -$1.97M

Similar funds

Caption Management's Q2 2019 Portfolio in Review

As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.

By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.

  • Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
  • Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
  • Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
  • Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
  • Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
  • Caption Management opened 395 new positions and closed 294 in Q2 2019.
  • Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.

Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.